Archived News for Health Sector Professionals - June, 2024
Research suggests experiencing racism may rewire the brain and accelerate ageing.
Vaccine helps NT hearing
First Nations children in the NT can access a vaccine that effectively reduces the risk of hearing loss.
VR aids birthing distraction
Virtual reality can significantly reduce pain and anxiety for women during labour.
Lung disease study funded
The Queensland Government is funding a new research initiative for occupational dust lung diseases.
Blood tests for concussion recovery
Blood tests could track the recovery of concussed football players.
Serco slammed for COVID standards
The Australian Antarctic Division (AAD) has criticised Serco, the private operator of Australia’s icebreaker RSV Nuyina, for not adhering to strict COVID-19 vaccination protocols.
New funds for NDIS redesign
The Australian government has pledged to co-design changes to the National Disability Insurance Scheme (NDIS) with the disability community.
AI aids baby brain watch
Artificial intelligence could revolutionise the monitoring of brain development in children.
Strong results for lung drug
A new drug has been described as a “remarkable advancement in lung cancer”.
Gene-editor shrunk
Researchers say gene-editing technology can be reduced in size and delivered by a virus.
Pollution toll tallied
Scientists say pollution presents a greater threat to global health than war, terrorism, and a range of diseases combined.
Bilingual babies learn early
Researchers have discovered that babies can perceive multiple languages while still in the womb.
Health tech courses enhanced
People living with disabilities in Victoria are set to benefit from an increase in locally manufactured assistive devices.
Mpox clusters emerge
Queensland has reported its largest mpox cluster to date, with 10 locally acquired cases recorded this month.
New link for vaccine advance
The University of Queensland (UQ) is partnering with Emory University in the US to enhance vaccine research.
Nuclear tech in cancer fight
ANSTO researchers have made a potentially groundbreaking advance in cancer treatment.